Xolair, an antibody asthma drug, was recently approved for severe food allergic reactions. It is not the first biological drug to treat multiple conditions. But it is the first to treat severe food ...
STANFORD -- A new study finds that the asthma medication Xolair may substantially reduce severe allergic reactions in people who have multiple food allergies and are accidentally exposed to those ...
Seeking Alpha: Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever ...
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head ...
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever ...
A new study finds that the asthma medication Xolair may substantially reduce severe allergic reactions in people who have multiple food allergies and are accidentally exposed to those foods. Data ...
Nasdaq: Regeneron and Sanofi Announce Dupixent Outperformance over Xolair in Phase 4 EVEREST Trial Results for CRSwNP and Asthma
Regeneron and Sanofi Announce Dupixent Outperformance over Xolair in Phase 4 EVEREST Trial Results for CRSwNP and Asthma
CBS News: New data shows asthma medicine may help reduce severe food allergy reactions
New data shows asthma medicine may help reduce severe food allergy reactions
Business Wire: FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications
CHICAGO (WGN) — For decades, asthma patients have used a drug to help them breathe better. Now, the Food and Drug Administration has given the nod to use that drug to reduce serious reactions from ...